课题基金 / 基金详情

Role of miRNA and posttranslational modifications as modulators of the functionality of high-density lipoprotein (HDL) in chronic kidney disease

Role of miRNA and posttranslational modifications as modulators of the functionality of high-density lipoprotein (HDL) in chronic kidney disease
miRNA 和翻译后修饰作为高密度脂蛋白 (HDL) 功能调节剂在慢性肾病中的作用
批准号:
351483950
负责人:
Professor Dr. Thimoteus Speer, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2017-12-31

项目摘要

项目成果

Professor Dr. Thimoteus Speer, Ph.D.的其他基金

相似基金

相关文献

中文摘要
翻译
慢性肾脏疾病(CKD)是血管事件发生的最强风险因素之一。其内在机制至今仍知之甚少。然而,已知内皮功能障碍、血管损伤的再生受损以及促炎微环境可促进肾功能受损患者的血管疾病。在我们以前的工作中,我们能够证明尿毒症将脂蛋白HDL和LDL转化为有害颗粒,从而诱导内皮功能障碍。此外,我们揭示了这些脂蛋白的结构表型和功能之间的强关联。除了蛋白质组成的定量和定性改变外,HDL的翻译后蛋白质修饰可能是其功能的重要调节剂。此外,HDL作为miRNA的载体,将它们运送到各种不同的细胞。然而,这种改变的HDL在特定疾病条件下的结构的相关性-特别是CKD -必须determined.It是本项目的目的是研究如何翻译后蛋白质修饰(第1部分)以及HDL相关的miRNA(第2部分)调节HDL对血管再生和炎症细胞活化的影响。在翻译研究设计中,将使用从不同程度肾损害患者以及健康受试者中分离的HDL。在第一部分中,我们将分析CKD患者HDL相关蛋白的翻译后修饰。使用来自这些患者、健康受试者的HDL以及离体修饰的HDL,将研究这些HDL制剂对血管再生的影响。为此,我们将使用不同的体外(增殖、迁移、血管生成)和体内试验(鼠颈动脉损伤模型/基质胶塞试验)。此外,我们的目标是确定HDL通过激活先天免疫系统促进促炎微环境。在第二部分中,我们将研究CKD患者和健康受试者之间HDL相关miRNA谱的差异。我们将分析特定HDL相关miRNA如何干扰内皮细胞和单核细胞的功能特性来调节血管再生和炎症细胞活化。总之,这些研究将有助于更好地理解促进血管疾病的生理和病理生理过程,特别是在CKD患者中。此外,我们的目标是确定HDL相关的miRNA以及HDL的翻译后蛋白修饰作为新的治疗靶点和/或生物标志物。
英文摘要
Chronic kidney disease (CKD) represents one of the strongest risk factor for the occurrence of vascular events. The underlying mechanisms have yet been poorly understood. However, it is known that endothelial dysfunction, impaired regeneration of vascular lesions as well as a proinflammatory microenvironment may promote vascular diseases in patients with impaired renal function. In our previous work, we were able to document that uremia transforms the lipoproteins HDL and LDL into noxious particles, which induce endothelial dysfunction. Moreover, we revealed a strong associated between the structural phenotype and the functionality of these lipoproteins. Besides quantitative and qualitative alterations of the protein composition, posttranslational proteins modifications of HDL might represent a crucial modulator of its functionality. Moreover, HDL serves as a carrier for miRNA and conveys them to a variety of distinct cells. However, the relevance of such an altered structure of HDL under specific disease conditions - particularly CKD - has to be determined.It is the aim of the present project to examine on how posttranslational protein modifications (part 1) as well as HDL-associated miRNA (part 2) modulate the effects of HDL on vascular regeneration and inflammatory cell activation. In a translational study design, HDL isolated from patients with different degrees of renal impairment as well as healthy subjects will be used.In part 1, we will analyze posttranslational modifications of HDL-associated proteins in patients with CKD. Using HDL from these patients, healthy subjects as well as ex vivo modified HDL, the effects of these HDL preparations on vascular regeneration will be studied. For this purpose, we will use distinct in vitro (proliferation, migration, angiogenesis) and in vivo assays (murine carotid injury model/matrigel plug assay). Moreover, we aim to determine on HDL contributes to a proinflammatory microenvironment by activating the innate immune system.In part 2, we will study differences in the profile of HDL-associated miRNA between patients with CKD and healthy subjects. We will then analyze on how specific HDL-associated miRNA interfere with the functional properties of endothelial cells and monocytes to regulate vascular regeneration and inflammatory cell activation.In summary, these studies should contribute to a better understanding of the physiological und pathophysiological processes promoting vascular disease in general and particularly in patients with CKD. Moreover, we aim to identify HDL-associated miRNA as well as posttranslational protein modifications of HDL as novel therapeutic targets and/or biomarkers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Einfluss von High-Density Lipoprotein auf die Endothelfunktion in Abhängigkeit vom Stadium der Chronischen Niereninsuffizienz
  • 批准号:
    167682516
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $0.0万
  • 财政年份:
    2010
  • 负责人:
    Professor Dr. Thimoteus Speer, Ph.D.
  • 依托单位:
国内基金
海外基金
血清外泌体中高表达的miRNA-148a在阿尔茨海默病进展中的作用机制研究
M2型巨噬细胞来源外泌体中miRNA-21下调KLF5抑制心肌梗死中脂毒性的作用及机制研究
  • 批准号:
    2026JJ81356
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    彭漪
  • 依托单位:
基于外泌体miRNA标志物的老年乳腺癌化疗毒性预测模型构建及护理干预路径优化
  • 批准号:
    2026JJ80561
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    孟火娟
  • 依托单位:
靶向CDH1 调控相关的miRNA 在早发性胃癌中的作用机制及诊断价值研究
  • 批准号:
    ZCLMRY26H2003
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张毅敏
  • 依托单位: